nanoView Diagnostics
Boston, US · Founded 2015 · Delaware corporation
Find your way into nanoView Diagnostics
Sign up to see every warm intro you have to nanoView Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the nanoView Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MR
Michael RubinNamed on SEC filing
PC
Parker CassidyNamed on SEC filing
GW
Gerald WilliamsonNamed on SEC filing
GD
George DaaboulNamed on SEC filing
DF
David FreedmanNamed on SEC filing
IR
Ian RatcliffeNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$17.5M disclosed across 3 rounds · 2018–2022
▶$2.5MraisedMar 2022 · 2 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMar 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- GERALD WILLIAMSONExecutive Officer, Director
- PARKER CASSIDYDirector
- GEORGE DAABOULDirector
- ANDREA JACKSONDirector
- DAVID FREEDMANExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2.5M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedDec 2020 · 4 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George DaaboulDirector
- Parker CassidyDirector
- Ian RatcliffeDirector
- David FreedmanExecutive Officer
- Andrea JacksonDirector
- Gerald WilliamsonExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedOct 2018 · 3 investors · BiotechnologyRule 506(b)
▶$9MraisedOct 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael RubinDirector
- Parker CassidyDirector
- Gerald WilliamsonExecutive Officer, Director
- George DaaboulExecutive Officer, Director
- David FreedmanExecutive Officer
- Ian RatcliffeDirector
- Offering amount
- $10M
- Amount sold
- $9M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has nanoView Diagnostics raised?
- nanoView Diagnostics has disclosed $17.5M raised across 3 rounds.
- Where is nanoView Diagnostics headquartered?
- nanoView Diagnostics is headquartered in Boston, US.